James R Meyers Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for James R Meyers.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of James R Meyers. James R Meyers is a EVP Worldwide Commercial Ops in GILEAD SCIENCES INC ($GILD) and a SVP Comm Ops North America in GILEAD SCIENCES INC ($GILD) and a Director in SANGAMO THERAPEUTICS, INC ($SGMO) and a Director in Arbutus Biopharma Corp ($TKMR) and a Director in CytomX Therapeutics, Inc. ($CTMX).

Over the past year James R Meyers has been an insider in 3 companies. The total value of shares held by James R Meyers in these companies amounts to $28,875.

James R Meyers Director
Arbutus Biopharma Corp
Director
CytomX Therapeutics, Inc.
EVP Worldwide Commercial Ops, SVP Comm Ops North America
GILEAD SCIENCES INC
Director
SANGAMO THERAPEUTICS, INC
$ 28875 The total value of shares held by James R Meyers
Insider Rank

James R Meyers ranks 33,110 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY 94404 CA

Companies in which James R Meyers is an Insider

Arbutus Biopharma Corp

Trading Symbol: TKMR
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James R Meyers: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 01 2020
$TKMR Market Capitalization: $138.47M
$TKMR Previous Close: $2.55

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

CytomX Therapeutics, Inc.

Trading Symbol: CTMX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James R Meyers: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 19 2020
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

GILEAD SCIENCES INC

Trading Symbol: GILD
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James R Meyers: EVP Worldwide Commercial Ops, SVP Comm Ops North America
Holdings: 2,936 shares
Current Value: $214,710
Latest Transaction: Feb 23 2018
$GILD Market Capitalization: $88.05B
$GILD Previous Close: $73.13

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 18x
Sell: 15x
Shares Bought: 188,111
Shares Sold: 178,512
Share Difference: +9,599
Value Difference: +$10,126,303

SANGAMO THERAPEUTICS, INC

Trading Symbol: SGMO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of James R Meyers: Director
Holdings: 7,500 shares
Current Value: $28,875
Latest Transaction: May 20 2020
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85

Last 4 weeks trend: STRONG BUY
Last 3 months trend: STRONG BUY View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 7,500
Shares Sold: 0
Share Difference: +7,500
Value Difference: $0

Latest Insider Trading Transactions of James R Meyers

Sentiment: All, TKMR, CTMX, GILD, SGMO

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 19 2020CTMXCytomX Therapeutic ...Meyers James RDirectorOption ExerciseA8.3520,000167,00020,000
Jun 01 2020TKMRArbutus Biopharma ...Meyers James RDirectorOption ExerciseA2.1622,00047,52022,000
May 20 2020SGMOSANGAMO THERAPEUTI ...Meyers James RDirectorOption ExerciseA10.4615,000156,90015,000
May 20 2020SGMOSANGAMO THERAPEUTI ...Meyers James RDirectorGrantA0.002,50007,5005 K to 7.5 K (+50.00 %)
Nov 26 2019SGMOSANGAMO THERAPEUTI ...Meyers James RDirectorOption ExerciseA9.8130,000294,30030,000
Nov 26 2019SGMOSANGAMO THERAPEUTI ...Meyers James RDirectorGrantA0.005,00005,0000 to 5 K
Aug 20 2019TKMRArbutus Biopharma ...Meyers James RDirectorOption ExerciseA1.5022,00033,00022,000

View all James R Meyers insider transactions.